Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018

Emi Takashita; Chiharu Kawakami; Hiroko Morita; Rie Ogawa; Seiichiro Fujisaki; Masayuki Shirakura; Hideka Miura; Kazuya Nakamura; Noriko Kishida; Tomoko Kuwahara; Keiko Mitamura; Takashi Abe; Masataka Ichikawa; Masahiko Yamazaki; Shinji Watanabe; Takato Odagiri; on behalf of the Influenza Virus Surveillance Group of Japan

doi:10.2807/1560-7917.ES.2019.24.3.1800698

Rapid communication Open Access

Like 0

Download

Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018
Emi Takashita¹ , Chiharu Kawakami² , Hiroko Morita¹ , Rie Ogawa¹ , Seiichiro Fujisaki¹ , Masayuki Shirakura¹ , Hideka Miura¹ , Kazuya Nakamura¹ , Noriko Kishida¹ , Tomoko Kuwahara¹ , Keiko Mitamura³ , Takashi Abe⁴ , Masataka Ichikawa⁵ , Masahiko Yamazaki⁶ , Shinji Watanabe¹ , Takato Odagiri¹ , on behalf of the Influenza Virus Surveillance Group of Japan⁷
View Affiliations Hide Affiliations

Affiliations: ¹ Influenza Virus Research Center, National Institute of Infectious Diseases, Tokyo, Japan ² Yokohama City Institute of Public Health, Kanagawa, Japan ³ Eiju General Hospital, Tokyo, Japan ⁴ Abe Children’s Clinic, Kanagawa, Japan ⁵ Ichikawa Children’s Clinic, Kanagawa, Japan ⁶ Zama Children’s Clinic, Kanagawa, Japan ⁷ The members of the group are listed at the end of the article

Correspondence:
Takato Odagiri
todagiri nih.go.jp
View Citation Hide Citation

Citation style for this article: Takashita Emi, Kawakami Chiharu, Morita Hiroko, Ogawa Rie, Fujisaki Seiichiro, Shirakura Masayuki, Miura Hideka, Nakamura Kazuya, Kishida Noriko, Kuwahara Tomoko, Mitamura Keiko, Abe Takashi, Ichikawa Masataka, Yamazaki Masahiko, Watanabe Shinji, Odagiri Takato, on behalf of the Influenza Virus Surveillance Group of Japan. Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018. Euro Surveill. 2019;24(3):pii=1800698. https://doi.org/10.2807/1560-7917.ES.2019.24.3.1800698 Received: 21 Dec 2018; Accepted: 16 Jan 2019

Abstract

The novel cap-dependent endonuclease inhibitor baloxavir marboxil was approved for the treatment of influenza virus infection in Japan in February 2018. Two influenza A(H3N2) viruses carrying an I38T substitution in the polymerase acidic subunit (PA) were detected in baloxavir-treated children in December 2018. This mutation is known to confer reduced susceptibility to baloxavir, and the two mutant viruses exhibited 76- and 120-fold reduced susceptibility to baloxavir.

This work is licensed under a Creative Commons Attribution 4.0 International License.

Article metrics loading...

/content/10.2807/1560-7917.ES.2019.24.3.1800698

2019-01-17

2024-11-21

Click here for cited by

http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2019.24.3.1800698

Full text loading...

/deliver/fulltext/eurosurveillance/24/3/eurosurv-24-3-4.html?itemId=/content/10.2807/1560-7917.ES.2019.24.3.1800698&mimeType=html&fmt=ahah

References

Koszalka P, Tilmanis D, Hurt AC. Influenza antivirals currently in late-phase clinical trial. Influenza Other Respir Viruses. 2017;11(3):240-6. https://doi.org/10.1111/irv.12446 PMID: 28146320
Hayden FG, Sugaya N, Hirotsu N, Lee N, de Jong MD, Hurt AC, et al. Baloxavir marboxil for uncomplicated influenza in adults and adolescents. N Engl J Med. 2018;379(10):913-23. https://doi.org/10.1056/NEJMoa1716197 PMID: 30184455
Omoto S, Speranzini V, Hashimoto T, Noshi T, Yamaguchi H, Kawai M, et al. Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil. Sci Rep. 2018;8(1):9633. https://doi.org/10.1038/s41598-018-27890-4 PMID: 29941893
Takashita E, Morita H, Ogawa R, Nakamura K, Fujisaki S, Shirakura M, et al. Susceptibility of influenza viruses to the novel cap-dependent endonuclease inhibitor baloxavir marboxil. Front Microbiol. 2018;9(3026):3026. https://doi.org/10.3389/fmicb.2018.03026 PMID: 30574137
Aoki FY, Boivin G, Roberts N. Influenza virus susceptibility and resistance to oseltamivir. Antivir Ther. 2007;12(4 Pt B):603-16. PMID: 17944268
Influenza Research Database (IRD). Analyze Sequence Variation (SNP). Bethesda: National Institute of Allergy and Infectious Diseases. [Accessed: 15 Jan 2019]. Available from: https://www.fludb.org
National Institute of Infectious Diseases (NID). Antiviral resistance surveillance in Japan. Tokyo: NID. [Accessed: 15 Jan 2019]. Available from: http://www.nih.go.jp/niid/en/influ-resist-e.html
World Health Organization. Meetings of the WHO working group on surveillance of influenza antiviral susceptibility – Geneva, November 2011 and June 2012. Wkly Epidemiol Rec. 2012;87(39):369-74. PMID: 23061103

Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018

Citation style for this article: <a href="/search?value1=Emi+Takashita&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Takashita Emi</a>, <a href="/search?value1=Chiharu+Kawakami&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Kawakami Chiharu</a>, <a href="/search?value1=Hiroko+Morita&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Morita Hiroko</a>, <a href="/search?value1=Rie+Ogawa&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Ogawa Rie</a>, <a href="/search?value1=Seiichiro+Fujisaki&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Fujisaki Seiichiro</a>, <a href="/search?value1=Masayuki+Shirakura&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Shirakura Masayuki</a>, <a href="/search?value1=Hideka+Miura&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Miura Hideka</a>, <a href="/search?value1=Kazuya+Nakamura&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Nakamura Kazuya</a>, <a href="/search?value1=Noriko+Kishida&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Kishida Noriko</a>, <a href="/search?value1=Tomoko+Kuwahara&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Kuwahara Tomoko</a>, <a href="/search?value1=Keiko+Mitamura&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Mitamura Keiko</a>, <a href="/search?value1=Takashi+Abe&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Abe Takashi</a>, <a href="/search?value1=Masataka+Ichikawa&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Ichikawa Masataka</a>, <a href="/search?value1=Masahiko+Yamazaki&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Yamazaki Masahiko</a>, <a href="/search?value1=Shinji+Watanabe&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Watanabe Shinji</a>, <a href="/search?value1=Takato+Odagiri&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Odagiri Takato</a>, <a href="/search?value1=on+behalf+of+the+Influenza+Virus+Surveillance+Group+of+Japan&option1=author&noRedirect=true" class="nonDisambigAuthorLink">on behalf of the Influenza Virus Surveillance Group of Japan</a>. Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018. <a href="/content/ecdc">Euro Surveill.</a> 2019;24(3):pii=1800698. <a href="https://doi.org/10.2807/1560-7917.ES.2019.24.3.1800698" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2019.24.3.1800698</a> Received: 21 Dec 2018;   Accepted: 16 Jan 2019

/content/10.2807/1560-7917.ES.2019.24.3.1800698

Data & Media loading...

Submit comment

Comment moderation successfully completed

Submit your article here

Submit an Article

Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018

Abstract

Click here for cited by